Educational content, not medical advice. This article explains general information about low blood sugar and GLP-1 medications. It does not recommend a medication, a dose, or any change to your treatment, and it is not a substitute for the personal hypoglycemia plan your own care team gives you.

Low blood sugar is one of the topics people arrive at already frightened, usually because they have read a list of symptoms without the context that decides whether the list applies to them. So here is the context first.

GLP-1 receptor agonists rarely cause hypoglycemia on their own. What changes that picture is what else is in your medicine cabinet. This article covers why a GLP-1 by itself is low risk, which two drug classes change the arithmetic, what a low actually feels like, the response clinicians commonly teach, when the situation stops being something to manage at home, and the small set of details worth writing down so that a prescriber can tell the causes apart.

Why a GLP-1 alone rarely drops you low

The useful phrase here is glucose-dependent. The glucose-lowering effect of a GLP-1 is largely tied to how much glucose is present: it does its work when blood sugar is rising after food, and it eases off as glucose returns toward normal. It is less like a switch that pushes glucose down regardless, and more like a response that scales with the situation.

That is the reason a GLP-1 taken by itself, without other glucose-lowering medication, is considered low risk for hypoglycemia. For someone taking one of these medications for weight management with no diabetes and no other diabetes drugs, true lows are uncommon.

None of that makes the topic irrelevant. It just means the question is not really "does this drug cause lows" but "what else am I taking, and what else is going on today".

The two drug classes that change the picture

The risk of hypoglycemia rises substantially when a GLP-1 is combined with insulin or with a sulfonylurea. Those two classes lower glucose whether or not glucose is already low, so adding a GLP-1 on top of them stacks one glucose-lowering effect onto another.

This is exactly why prescribers often adjust insulin or sulfonylurea doses when a person starts a GLP-1. That adjustment is a clinical decision, made by the clinician who prescribes those medicines, using your readings, your history and their judgment. We will not print numbers for it, because there are none that belong in a general article: the right change for one person is the wrong change for another, and this is precisely the sort of decision that has to be made by someone who knows your case.

What that does mean for you is that the conversation before starting matters. If you take insulin or a sulfonylurea and a GLP-1 is being added, the questions worth asking out loud are how your other doses will be handled, how often you should be checking, and what your personal plan is if a reading comes back low.

Two everyday circumstances add to the risk on top of the medication mix: skipped or delayed meals, which are easy to fall into when a GLP-1 has quieted your appetite, and unusually intense or unusually long exercise. Neither is a reason to avoid either thing. They are simply the days to be more attentive.

What a low feels like

Symptoms commonly listed include shakiness, sweating, dizziness, confusion, a rapid heartbeat, sudden hunger, headache and blurred vision. They can arrive quickly, and they overlap uncomfortably with plenty of other experiences: anxiety, dehydration, standing up too fast, or the general flatness of a week where you have been eating much less than usual.

That overlap is the reason a meter matters for anyone at real risk. Hypoglycemia is defined by a reading, not by a sensation, and treating a feeling as a diagnosis leads people either to over-treat something that was not a low or to dismiss something that was. If you have a meter or a sensor and you feel any of these things, check.

Dizziness in particular has a long list of possible causes on a GLP-1, most of them not blood sugar at all; we untangled that list in our article on dizziness on a GLP-1.

GLP 1 Tracker AppFree on the App Store. Log doses, meals, activity and symptoms on one timeline, so timing questions have answers. Get the app

The 15-15 rule, and why it is not the whole plan

The response clinicians commonly teach people at risk of lows is known as the 15-15 rule. In its standard form: if a reading is below 70 mg/dL, take about 15 grams of fast-acting carbohydrate, wait about 15 minutes, then re-check, and repeat if the reading is still low.

Fast-acting means simple sugar that gets in quickly, which in practice usually means glucose tablets, juice, or regular (not diet) soda. Foods with fat in them, chocolate being the classic example, are slower to act, which is why the standard teaching favors the plain options even though they are less appealing.

Two things about that rule deserve saying plainly. First, it is patient education taught by clinicians, not a substitute for one: it is the shape of the standard response, and it exists because having a rehearsed script beats improvising while your thinking is impaired.

Second, if you are genuinely at risk of lows, your plan should come from your own care team, not from a website. Your threshold, your target, what you should carry, how often to re-check, when to call, and how any of it changes on a sick day or a long run are all details that belong to a personal plan. Ask for one, and keep it somewhere you can find it without thinking.

When it stops being a home situation

There is a line, and it is worth knowing before you need it. Someone who cannot self-treat, is confused, is having a seizure, or has lost consciousness needs emergency help immediately. That is a call for emergency services, not a moment to wait fifteen minutes and see.

Someone in that state should not be given food or drink by mouth, because they cannot safely swallow. If glucagon has been prescribed, this is what it is for, and it only helps if the people around you know that it exists, where it is kept, and how to use it. Telling a partner, a housemate, or a colleague once, before anything happens, is a small act with a very large payoff.

Repeated lows, lows at night, or lows you did not feel coming are all reasons to contact your prescriber promptly rather than at the next scheduled visit, even when each individual episode resolved fine.

Shaky without diabetes is usually a different problem

A lot of people taking a GLP-1 for weight management, with no diabetes and no glucose-lowering medication, describe feeling shaky, weak, lightheaded or oddly irritable, and reasonably wonder whether their blood sugar has crashed.

Usually it has not. What is far more common in that situation is simply not eating enough. Appetite has gone quiet, breakfast did not happen, lunch was three bites, and by mid-afternoon the body is running on very little. The symptoms feel similar; the cause and the fix are different. Eating regularly, with attention to protein, is a more useful response than treating a low that is not there. Our guide to protein goals on GLP-1s covers how to get enough in when nothing sounds good.

The clean way to hold the distinction is this: hypoglycemia is a number. If you have a meter and the number is low, that is a low. If you do not, and you have no reason to be at risk, what you have is a symptom worth mentioning to your clinician rather than a diagnosis to act on.

What to track, and why timing is the whole thing

The single most useful thing you can bring to a prescriber on this topic is not a description of how the episode felt. It is when it happened relative to everything else.

Worth noting each time:

  • Time of day, and the meter reading if you took one
  • What you had eaten and how long before
  • How long since your last GLP-1 dose, and where you are in your titration
  • Any exercise that was longer or harder than usual
  • What it took to feel normal again, and how long that took

Those five lines are what let a clinician separate a genuine low from under-eating, from dehydration, from a side effect of the medication itself, or from something unrelated to any of it. Clustering is the giveaway: symptoms that always land two hours after your longest gap without food tell a different story from symptoms that always land the day after your shot.

In GLP 1 Tracker App this falls out of ordinary logging rather than requiring a special effort. Doses, food, activity, water and a side effect diary with severity all sit on the same timeline in the free tier, so "how long after my dose" and "how long after eating" are things you can read rather than reconstruct. Premium adds 90-day side effect trends if a pattern needs a longer view. Our guide to bringing data to your appointment covers turning that into a two minute answer at the visit, and sick day rules covers the days when eating and drinking themselves become the problem.

The takeaway

A GLP-1 on its own is low risk for hypoglycemia, because its glucose-lowering effect is largely glucose-dependent. Insulin and sulfonylureas are what change that, which is why prescribers often adjust those medicines when a GLP-1 is added and why that decision stays with them. Know the symptoms, know the 15-15 response, know that anything involving confusion or loss of consciousness is an emergency call, and get a personal plan from your care team if you are genuinely at risk. Then log the timing, because timing is the part nobody remembers accurately and the part your prescriber most needs.

Try it freeNo account, no ads. Doses, meals and symptoms on one private timeline. Download

Frequently asked questions

Can Ozempic or Wegovy cause low blood sugar?

On their own, GLP-1 receptor agonists rarely cause hypoglycemia. Their glucose-lowering effect is largely glucose-dependent, which means it eases off as glucose falls toward normal, and that is why a GLP-1 by itself is considered low risk for lows. The risk rises substantially when a GLP-1 is combined with insulin or a sulfonylurea, which lower glucose whether or not it is already low.

What is the 15-15 rule for low blood sugar?

It is the standard patient education clinicians commonly teach: if a reading is below 70 mg/dL, take about 15 grams of fast-acting carbohydrate such as glucose tablets, juice or regular soda, wait about 15 minutes, and re-check, repeating if the reading is still low. Anyone at real risk of lows should have a personal plan from their own care team rather than relying on a general rule from a website.

Will my insulin dose change when I start a GLP-1?

It may. Prescribers often adjust insulin or sulfonylurea doses when someone starts a GLP-1, precisely because the combination raises the risk of lows. That adjustment is a clinical decision made by the person who prescribes those medicines, based on your readings and your history. It is not something to work out from an article, and it is the reason the conversation before starting matters.

Can you get low blood sugar on a GLP-1 without diabetes?

True hypoglycemia is uncommon in people taking a GLP-1 for weight management without diabetes and without glucose-lowering medications. Feeling shaky, lightheaded or weak is much more often the result of simply not eating enough while appetite is suppressed. The distinction matters because hypoglycemia is defined by a meter reading, not by a feeling, and the two situations have different answers.

What are the symptoms of low blood sugar?

Commonly listed symptoms include shakiness, sweating, dizziness, confusion, a rapid heartbeat, sudden hunger, headache and blurred vision. They can come on quickly and they are easy to mistake for other things. Someone who cannot self-treat, is confused, is having a seizure, or has lost consciousness needs emergency help immediately, and should never be given anything by mouth.